StreetInsider.com News Articles

Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: S

Thu, 22 Oct 2026 08:29:43 -0400

PHILADELPHIA, Oct. 22, 2026 (GLOBE NEWSWIRE) --

Beta Bionics, Inc. (NASDAQ: BBNX):

Grabar Law Office is investigating claims on behalf of shareholders of Beta Bionics, Inc. (NASDAQ: BBNX).

What is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Beta Bionics, Inc. (NASDAQ: BBNX) shares prior to July 30, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at

Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: S

Thu, 22 Oct 2026 08:29:43 -0400

PHILADELPHIA, Oct. 22, 2026 (GLOBE NEWSWIRE) --

Beta Bionics, Inc. (NASDAQ: BBNX):

Grabar Law Office is investigating claims on behalf of shareholders of Beta Bionics, Inc. (NASDAQ: BBNX).

What is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Beta Bionics, Inc. (NASDAQ: BBNX) shares prior to July 30, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at

Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: S

Thu, 22 Oct 2026 08:29:43 -0400

PHILADELPHIA, Oct. 22, 2026 (GLOBE NEWSWIRE) --

Beta Bionics, Inc. (NASDAQ: BBNX):

Grabar Law Office is investigating claims on behalf of shareholders of Beta Bionics, Inc. (NASDAQ: BBNX).

What is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Beta Bionics, Inc. (NASDAQ: BBNX) shares prior to July 30, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at

Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: S

Thu, 22 Oct 2026 08:29:43 -0400

PHILADELPHIA, Oct. 22, 2026 (GLOBE NEWSWIRE) --

Beta Bionics, Inc. (NASDAQ: BBNX):

Grabar Law Office is investigating claims on behalf of shareholders of Beta Bionics, Inc. (NASDAQ: BBNX).

What is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Beta Bionics, Inc. (NASDAQ: BBNX) shares prior to July 30, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at

Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: S

Thu, 22 Oct 2026 08:29:43 -0400

PHILADELPHIA, Oct. 22, 2026 (GLOBE NEWSWIRE) --

Beta Bionics, Inc. (NASDAQ: BBNX):

Grabar Law Office is investigating claims on behalf of shareholders of Beta Bionics, Inc. (NASDAQ: BBNX).

What is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Beta Bionics, Inc. (NASDAQ: BBNX) shares prior to July 30, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at

Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: S

Thu, 22 Oct 2026 08:29:43 -0400

PHILADELPHIA, Oct. 22, 2026 (GLOBE NEWSWIRE) --

Beta Bionics, Inc. (NASDAQ: BBNX):

Grabar Law Office is investigating claims on behalf of shareholders of Beta Bionics, Inc. (NASDAQ: BBNX).

What is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Beta Bionics, Inc. (NASDAQ: BBNX) shares prior to July 30, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at

Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: S

Thu, 22 Oct 2026 08:29:43 -0400

PHILADELPHIA, Oct. 22, 2026 (GLOBE NEWSWIRE) --

Beta Bionics, Inc. (NASDAQ: BBNX):

Grabar Law Office is investigating claims on behalf of shareholders of Beta Bionics, Inc. (NASDAQ: BBNX).

What is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Beta Bionics, Inc. (NASDAQ: BBNX) shares prior to July 30, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at

Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: S

Thu, 22 Oct 2026 08:29:43 -0400

PHILADELPHIA, Oct. 22, 2026 (GLOBE NEWSWIRE) --

Beta Bionics, Inc. (NASDAQ: BBNX):

Grabar Law Office is investigating claims on behalf of shareholders of Beta Bionics, Inc. (NASDAQ: BBNX).

What is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Beta Bionics, Inc. (NASDAQ: BBNX) shares prior to July 30, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at

Procept BioRobotics Corp (PRCT) PT Lowered to $19 at Baird

Thu, 15 Oct 2026 07:22:38 -0400
Baird analyst David Rescott lowered the price target on Procept BioRobotics Corp (NASDAQ: PRCT) to $19.00 (from $20.00) while maintaining a Neutral rating.

PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026

Mon, 12 Oct 2026 16:05:00 -0400

SAN JOSE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third quarter of 2026 after market close on Wednesday, November 4, 2026. The Company’s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by following one of the below links:

Webcast link for

PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026

Mon, 12 Oct 2026 16:05:00 -0400

SAN JOSE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third quarter of 2026 after market close on Wednesday, November 4, 2026. The Company’s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by following one of the below links:

Webcast link for

Barclays Starts Procept BioRobotics Corp (PRCT) at Overweight

Tue, 06 Oct 2026 16:26:16 -0400

Barclays initiates coverage on Procept BioRobotics Corp (NASDAQ: PRCT) with a Overweight rating and a price target of $30.00.

For an analyst ratings summary and ratings history on Procept BioRobotics Corp click here. For more ratings news on Procept BioRobotics Corp click here.

Shares of Procept BioRobotics Corp closed at $17.82 yesterday.

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The

Tue, 06 Oct 2026 11:53:40 -0400

PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) --

Aardvark Therapeutics, Inc. (NASDAQ: AARD):

Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.

What is This Investigation About? The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The

Tue, 06 Oct 2026 11:53:40 -0400

PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) --

Aardvark Therapeutics, Inc. (NASDAQ: AARD):

Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.

What is This Investigation About? The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The

Tue, 06 Oct 2026 11:53:40 -0400

PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) --

Aardvark Therapeutics, Inc. (NASDAQ: AARD):

Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.

What is This Investigation About? The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The

Tue, 06 Oct 2026 11:53:40 -0400

PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) --

Aardvark Therapeutics, Inc. (NASDAQ: AARD):

Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.

What is This Investigation About? The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The

Tue, 06 Oct 2026 11:53:40 -0400

PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) --

Aardvark Therapeutics, Inc. (NASDAQ: AARD):

Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.

What is This Investigation About? The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The

Tue, 06 Oct 2026 11:53:40 -0400

PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) --

Aardvark Therapeutics, Inc. (NASDAQ: AARD):

Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.

What is This Investigation About? The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The

Tue, 06 Oct 2026 11:53:40 -0400

PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) --

Aardvark Therapeutics, Inc. (NASDAQ: AARD):

Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.

What is This Investigation About? The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The

Tue, 06 Oct 2026 11:53:40 -0400

PHILADELPHIA, Oct. 06, 2026 (GLOBE NEWSWIRE) --

Aardvark Therapeutics, Inc. (NASDAQ: AARD):

Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.

What is This Investigation About? The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects

Form 3 PROCEPT BioRobotics Corp For: Oct 02 Filed by: Mack Michael

Mon, 05 Oct 2026 16:10:00 -0400
si-local-file:///var/storage/secattach/20261005/27148850.html

Form 4 PROCEPT BioRobotics Corp For: Oct 02 Filed by: Mack Michael

Mon, 05 Oct 2026 16:10:00 -0400
si-local-file:///var/storage/secattach/20261005/27148870.html

Form 8-K PROCEPT BioRobotics Corp For: Oct 02

Fri, 02 Oct 2026 16:47:00 -0400
si-local-file:///var/storage/secattach/20261002/27143127.html

GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); New Era Energy & Digital, Inc. (NASDAQ: NUAI); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT):

Fri, 02 Oct 2026 08:25:29 -0400

PHILADELPHIA, Oct. 02, 2026 (GLOBE NEWSWIRE) --

GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI):

Grabar Law Office is investigating claims on behalf of shareholders of GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO).

What Is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO) shares prior to November 3, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to

GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); New Era Energy & Digital, Inc. (NASDAQ: NUAI); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT):

Fri, 02 Oct 2026 08:25:29 -0400

PHILADELPHIA, Oct. 02, 2026 (GLOBE NEWSWIRE) --

GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI):

Grabar Law Office is investigating claims on behalf of shareholders of GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO).

What Is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO) shares prior to November 3, 2025, and still hold shares today, you can seek corporate reforms, the return of funds back to